Latest News Archive

Please select Category, Year, and then Month to display items

UFS to present December 2021 graduation ceremonies virtually

01 December 2021 | Story Dr Nitha Ramnath

The University of the Free State will present the December 2021 graduation ceremonies virtually from 8 to 13 December 2021. The recent changes in our environment due to the discovery of the Omicron variant, and the increase in COVID-19 infection rates in South Africa, have required us to re-assess our plans. This was also addressed as a matter of concern by President Cyril Ramaphosa during the family meeting on 28 November 2021.

After careful consideration of the risks of presenting face-to-face graduation ceremonies, the executive management of the University of the Free State (UFS) has decided to adjust all the ceremonies to virtual broadcasts.

The university community acknowledges your hard work and achievements in the midst of the many challenges you have faced. Despite not being able to meet in person, we are grateful that technology makes it possible to proceed with this significant event.

The graduation ceremonies will be broadcast as follows:

Faculty of Education, South Campus: Wednesday, 8 December 2021 at 09:00

Faculty of Education, South Campus graduands: Wednesday, 8 December 2021 at 11:00

Faculty of Education, Bloemfontein Campus and Qwaqwa Campus graduands: Thursday, 9 December 2021 at 09:00

Faculty of Economic and Management Sciences: Thursday, 9 December at 11:00

Faculty of Natural and Agricultural Sciences: Friday, 10 December at 09:00

Faculty of the Humanities: Friday, 10 December 2021 at 11:00

Faculties of Health Sciences, Law, and Theology and Religion: Monday, 13 December 2021 at 09:00

Congratulations to all our graduates; may you have continued success in all your endeavours!

News Archive

Nano research at the UFS opens door to smart drugs

2011-06-27

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences.

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.

Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).

Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.

These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept